News
Academy
Publications
All Publications
E-Books
Media
Editorial Podcasts
Editorial Videos
Peer Exchange
Practice Academy
Shorts
Sponsored Podcasts
Sponsored Videos
More
Conferences
Conference Coverage
Conference Listing
Columns
All Columns
A Closing Thought
Clinical Trial Insights
View from Brussels
View from Washington
Resources
Advertise
Blogs
Events
Front & Center
Partner Perspectives
White Papers
Events
Webcasts
Event Calendar
Subscribe
My Account
News
Academy
Publications
Media
Conferences
Columns
Resources
Events
Subscribe
Event Calendar
Clinical Operations & Strategy
Decentralized Clinical Trials
Trial Design
Investigative Sites
CRO/Sponsor
Risk-Based Monitoring
Protocol Design
Clinical Trial Supply Chain
Study Start-Up
Early Phase Development
DEI
Industry Initiatives
Diversity Action Plans
Recruitment
Data Management
Analytics
Electronic Data Capture
Real World Evidence
Metrics & Benchmarks
Patient Participation
Integrated Research
CRAACO
Enrollment
Regulatory
Institutional Review Board & Ethics Committee
FDA
EMA
Technology
Artificial Intelligence/Machine Learning
eClinical
mHealth
Choose Specialty
Spotlight -
Conference Coverage
|
Peer Exchange
|
DE&I
|
Editorial Videos
|
Clinical Operations & Strategy
|
Patient Participation
Advertisement
David Grunwald
Advertisement
Articles by David Grunwald
Medical Translation in Clinical Research
By
David Grunwald
January 24th 2013
Applied Clinical Trials
Advertisement
Latest Updated Articles
Medical Translation in Clinical Research
January 24th 2013
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations
2
When the Slack Runs Out: AI and the CRO Operating Model
3
What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed
4
ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment
5
Speed, Discipline, and the New Rules of Biotech Development: Q&A with Stella K. Vnook, PhD, Kaida BioPharma and Aviva Ventures